The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug Financial Times Business Book of the Year Nominee for Longlist (2013) is a thirty-year veteran of

is a thirty-year veteran of New York book and magazine publishing

To coincide with the release of AVP

and make the most of books' appealing visual and tactile qualities

to the distinctive way that managers and leaders define their roles

Philosophical and mysterious

The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug Financial Times Business Book of the Year Nominee for Longlist (2013) is a thirty-year veteran ofJoin journalist Barry Werth as he pulls back the curtain on Vertex, a start up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard and Merck trained scientific whiz kid, Vertex is dedicated to designingatom by atomboth a new life saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will